Solid self-microemulsifying drug delivery system of ritonavir

Drug Development and Industrial Pharmacy

Volumn 40, Issue 4, 2014, Pages 477-487

  Deshmukh, Ashish ^a   Kulkarni, Shirishkumar ^a  

^a AISSMS COLLEGE OF PHARMACY   (India)

Author keywords

Cosurfactant; Oil; Ritonavir; SMEDDS; Surfactant

Indexed keywords

CREMOPHOR; EXCIPIENT; OCTANOIN; RITONAVIR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG SOLUBILITY; IN VITRO STUDY; MALE; MAXIMUM PLASMA CONCENTRATION; MICROEMULSION; NONHUMAN; PH; PHASE SEPARATION; PLASMA CONCENTRATION-TIME CURVE; RAT; SOLID SELF MICROEMULSIFYING DRUG DELIVERY SYSTEM; TIME TO MAXIMUM PLASMA CONCENTRATION; X RAY DIFFRACTION;

ADMINISTRATION, ORAL; ALUMINUM COMPOUNDS; ANIMALS; AREA UNDER CURVE; BIOLOGICAL AVAILABILITY; CHEMISTRY, PHARMACEUTICAL; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; EMULSIONS; EXCIPIENTS; HIV PROTEASE INHIBITORS; MAGNESIUM COMPOUNDS; MALE; PARTICLE SIZE; RATS; RATS, WISTAR; RITONAVIR; SILICATES; SOLUBILITY; SURFACE-ACTIVE AGENTS; TABLETS; X-RAY DIFFRACTION;

EID: 84896728386     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.3109/03639045.2013.768632     Document Type: Article

References (30)

1. Norvir soft gelatin capsule, prescribing information. Available from: www.rxabbott.com/pdf/norpi2a.pdf [last accessed 2 August 2012].
2. Robert KZ, Richard AP. Pharmacological and therapeutic properties of ritonavir-boosted protease inhibitor therapy in HIV-infected patients. J Antimicro Chemo 2004;53:4-9.
3. George H. Bioequivalence of pilot tablet formulations of ritonavir (RTV) to the marketed soft gel capsule (SGC) at a dose of 100 mg. 14th CROI Conference on Retroviruses and Opportunistic Infections; 25-28 Feb 2007; Los Angeles, CA. Available from: http://www.natap.org/2007/CROI/croi-54.htm [last accessed 10 August 2012].
4. Shilpi S, Mushir A, Sanjula B, et al. Solid dispersion as an approach for bioavailability enhancement of poorly water-soluble drug ritonavir. AAPS PharmSciTech 2010;11:518-27.
5. Pranjali BG, Sanjay JK, Mangesh RB, Ashwini RM. Preparation and characterization of amorphous nanoparticles for solubility enhancement of ritonavir. Int J Pharm Inven 2012; 2:27-35.
6. Venkata DR, Chowdhary KPR. Formulation development of ritonavir tablets employing B cyclodextrin, solutol HS-15 and PVP-K30. Int J Pharm Res Dev 2012;4:45-50.
7. Lawrence MJ, Rees GD. Microemulsions-based media as novel drug delivery systems. Adv Drug Deliv Rev 2000;45:89-121.
8. Pouton CW. Lipid formulations for oral administration of drugs: non-emulsifying, self-emulsifying and self-microemulsifying drug delivery systems. Eur J Pharm Sci 2000;11:93-8.
9. Grove M, Mu00 llertz A, Nielsen JL, Pedersen GP. Bioavailability of seocalcitol II: development and characterization of selfmicroemulsifying drug delivery systems (SMEDDS) for oral administration containing medium and long chain triglycerides. Eur J Pharm Sci 2006;28:233-42.
10. Khang BK, Lee JS, Chon SK, et al. Development of selfmicroemulsifying drug delivery systems for oral bioavailability enhancement of simvastatin in beagle dogs. Int J Pharm 2004;274:65-73.
11. Gursoy RN, Benita S. Self-emulsifying drug delivery systems for improved oral delivery of lipophilic drugs. Biomed Pharmacother 2004;58:173-82.
12. Shyam V, Shruthi S, Cheng SC. Formulation and in vitro evaluation of self-emulsifying formulations of Cinnarizine. Drug Dev Ind Pharm 2011;38:1188-94.
13. Myung JK, Hyung SK, Ho SJ, et al. In situ intestinal permeability and in vivo absorption characteristics of olmesartan medoxomil in self-microemulsifying drug delivery system. Drug Dev Ind Pharm 2012;38:587-96.
14. Myung JK, Soo YJ, Woo HS, et al. Immediate release of ibuprofen from Fujicalin-based fast-dissolving self-emulsifying tablets. Drug Dev Ind Pharm 2011;37:1298-305.
15. Zhi QC, Ying L, Ji HZ, et al. Improved oral bioavailability of poorly water-soluble indirubin by a supersaturatable self-microemulsifying drug delivery system. Int J Nanomed 2012;7:1115-25.
16. Yongjun W, Jin S, Tianhong Z, et al. Enhanced oral bioavailability of tacrolimus in rats by self-microemulsifying drug delivery systems. Drug Dev Ind Pharm 2011;37:1225-30.
17. Oh DH, Kang JH, Kim DW, et al. Comparison of solid selfmicroemulsifying drug delivery system (solid SMEDDS) prepared with hydrophilic and hydrophobic solid carrier. Int J Pharm 2011;28:420, 412-18.
18. Paola M, Maurizio V, Marzia C, Natascia M. New solid selfmicroemulsifying systems to enhance dissolution rate of poorly water soluble drugs. Pharm Dev Tech 2012;17:277-84.
19. Dong WK, Jun HK, Dong HO, et al. Development of novel flurbiprofen-loaded solid self-microemulsifying drug delivery system using gelatin as solid carrier. J Microencapsul 2012;29:323-30.
20. Jun HK, Dong HO, Yu-K O, et al. Effects of solid carriers on the crystalline properties, dissolution and bioavailability of flurbiprofen in solid self-nanoemulsifying drug delivery system (solid SNEDDS). Eur J Pharm Biopharm 2012;80:289-97.
21. Venkata RK, Suresh B, Raju J, Prabhakar RV. Oral self emulsifying powder of lercanidipine hydrochloride: formulation and evaluation. Powder Tech 2012;221:375-82.
22. Srinivasan S, Rengarajan B, Prabagar B, et al. Solid selfnanoemulsifying drug delivery system (S-SNEDDS) containing phosphatidylcholine for enhanced bioavailability of highly lipophilic bioactive carotenoid lutein. Eur J Pharm Biopharm 2011;79:250-7.
23. Saipin S, Sirima M, Narubodee P, et al. Development and evaluation of self-microemulsifying liquid and pellet formulations of curcumin, and absorption studies in rats. Eur J Pharm Biopharm 2010; 76:475-85.
24. Ping L, Anasuya G, Robert FW, et al. Effect of combined use of non-ionic surfactant on formation of oil-in-water microemulsions. Int J Pharm 2005;88:27-34.
25. Ritonavir Capsules Authorized USP Non-US Monograph. Available from: http://www.usp.org/sites/default/files/usp-pdf/EN/nonUSStandards/m4796.pdf [last accessed 11 August 2012].
26. Patel D, Sawant KK. Oral bioavailability enhancement of acyclovir by self-microemulsifying drug delivery systems (SMEDDS). Drug Dev Ind Pharm 2007;33:1318-26.
27. Adhvait RD, Sadhana JR, Samir GP. Preparation and bioavailability assessment of SMEDDS containing valsartan. AAPS PharmSciTech 2010;11:314-21.
28. You ML, Jui YW, Ying CC, et al. In situ formation of nanocrystals from a self-microemulsifying drug delivery system to enhance oral bioavailability of fenofibrate. Int J Nanomed 2011;6:2445-57.
29. Camilla S, Per H. Porous magnesium aluminometasilicate tablets as carrier of a cyclosporine self-emulsifying formulation. AAPS PharmSciTech 2009;10:1388-95.
30. Law D, Schmitt EA, Marsh KC, et al. Ritonavir-PEG 8000 amorphous solid dispersions: in vitro and in vivo evaluations. J Pharm Sci 2004;93:563-70.